Delivery Order SPE2DB22D1202-SPE2DB25FUYH8

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,351.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity, a diabetes medication, under a Firm Fixed Price contract type. The contract has an ultimate completion date of April 24, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The award, valued at $1,161.12, is a delivery order for the supply of the prescription drug Trulicity, a medication used to treat Type 2 diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of August 12, 2024. This award is not associated with any set-aside program. As a...
This federal contract award, valued at $3,603.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Trulicity, a diabetes medication, with a performance period through May 2025. This contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support...
This federal contract award, valued at $2,102.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a diabetes medication, with an ultimate completion date of April 24, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,741.68 delivery order is for the drug Trulicity, a treatment for Type 2 diabetes. The contract has a firm fixed price and an ultimate completion date of October 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,484.88 firm fixed-price delivery order covers the supply of the drug Trulicity, a medication used for the treatment of diabetes. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,552.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the medication Trulicity 1.5 mg/0.5 ml pen, a treatment for diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a significant Indefinite...
This federal contract award, valued at $12,903.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Trulicity, a medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2025. This contract is not set-aside and represents an open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $22,600.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The delivery order contract is for the supply of the brand name medication Trulicity, a diabetes treatment. The firm fixed price contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp has received numerous prior awards from DLA to provide...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,741.68 firm fixed price delivery order is for the prescription drug Trulicity, a medication used to treat type 2 diabetes. The contract has a completion date of June 4, 2024 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUYH8
    Delivery Order

This federal contract award, valued at $1,570.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D1202|SPE2DB25FUYH8) for the drug Trulicity, a diabetes treatment medication. The contract has a firm fixed price pricing type and an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The current delivery order does not have a set-aside designation, indicating open competition.

Generated 7/18/25, 9:49 AM